Page 138 - 南京医科大学自然版
P. 138
第44卷第7期
·1022 · 南 京 医 科 大 学 学 报 2024年7月
SVZ 的偶然剂量。此外,患者之间较明显的异质性、 378-393
治疗方式的差异性等都限制了回顾性研究所得出结 [11]EVERS L,SCHÄFER A,PINI R,et al. Identification of
论的准确性。并且近年来的研究结果表明SVZ放疗 dysregulated microRNAs in glioblastoma stem ⁃ like
不一定能使患者获益,高剂量的放射性照射反而可能 cells[J]. Brain Sci,2023,13(2):350
[45]
会对患者带来更明显的放射相关不良反应 。 [12]WALLENBORN M,XU L X,KIRSTEN H,et al. Molecu⁃
lar analyses of glioblastoma stem⁃like cells and glioblasto⁃
目前有两项正在进行的关于 GBM 患者术后
ma tissue[J]. PLoS One,2020,15(7):e0234986
放 疗 照 射 SVZ 的 前 瞻 性 研 究(NCT02177578、
[13]SHIH L K,MUKHERJEE S,BRAT D J. Off the clock:the
NCT06092255),希望他们能够提供确切结果,以指
non⁃canonical roles of cyclin⁃dependent kinases in neural
导SVZ 放疗的价值与剂量。综上所述,为了更好地 and glioma stem cell self ⁃ renewal[J]. Mol Neurobiol,
指导GBM患者的治疗决策,需要进行更多的基础研
2022,59(11):6805-6816
究和临床研究,而这些研究将有助于深入了解 SVZ [14]BROCKMAN A A,MOBLEY B C,IHRIE R A. Histologi⁃
在GBM中的作用,并为未来的治疗策略制定提供科 cal studies of the ventricular⁃subventricular zone as neu⁃
学依据。 ral stem cell and glioma stem cell niche[J]. J Histochem
Cytochem,2021,69(12):819-834
[参考文献]
[15]BODEGRAVEN E J,SLUIJS J A,TAN A K,et al. New GFAP
[1] GULAIA V,KUMEIKO V,SHVED N,et al. Molecular
splice isoform(GFAPμ)differentially expressed in glioma
mechanisms governing the stem cell’s fate in brain can⁃
translates into 21 kDa N ⁃ terminal GFAP protein[J].
cer:factors of stemness and quiescence[J]. Front Cell
FASEB J,2021,35(3):e21389
Neurosci,2018,12:388
[16]ALDAZ P,MARTÍN ⁃ MARTÍN N,SAENZ ⁃ ANTOÑAN⁃
[2] LU Y B,SUN T J,CHEN Y T,et al. Targeting the epitheli⁃
ZAS A,et al. High SOX9 maintains glioma stem cell activity
al⁃to⁃mesenchymal transition in cancer stem cells for a
through a regulatory loop involving STAT3 and PML[J].
better clinical outcome of glioma[J]. Technol Cancer Res
Int J Mol Sci,2022,23(9):4511
Treat,2020,19:1533033820948053
[17]PARMIGIANI E,IVANEK R,ROLANDO C,et al. Inter⁃
[3] QIU J G,SHI Z,JIANG J X. Cyclooxygenase⁃2 in glioblas⁃ feron⁃γ resistance and immune evasion in glioma develop
toma multiforme[J]. Drug Discov Today,2017,22(1):
via Notch⁃regulated co⁃evolution of malignant and immune
148-156 cells[J]. Dev Cell,2022,57(15):1847-1865
[4] 龚俊杰,刘秀秀,王 平,等. 代谢组学在胶质母细胞瘤 [18]LI T T,LIU H M,JIANG D F,et al. BMP4 exerts anti⁃
相关研究中的应用[J]. 南京医科大学学报(自然科学 neurogenic effect via inducing Id3 during aging[J].
版),2021,41(2):296-305 Biomedicines,2022,10(5):1147
[5] HUANG B,LI X,LI Y,et al. Current immunotherapies for [19]HAN L Z,LI Z G,JIANG Y Q,et al. SNHG29 regulates
glioblastoma multiforme[J]. Front Immunol,2020,11: miR ⁃ 223 ⁃ 3p/CTNND1 axis to promote glioblastoma
603911 progression via Wnt/β⁃catenin signaling pathway[J]. Can⁃
[6] BRYUKHOVETSKIY I. Cell ⁃ based immunotherapy of cer Cell Int,2019,19:345
glioblastoma multiforme[J]. Oncol Lett,2022,23(4):133 [20]刘亚丹,谢甲贝,朱琼琼,等. 双特异性 CAR⁃T 细胞对
[7] BEIRIGER J,HABIB A,JOVANOVICH N,et al. The sub⁃ EGFRvⅢ /CD133 胶质瘤干细胞的靶向杀伤[J].中国
+
+
ventricular zone in glioblastoma:genesis,maintenance, 肿瘤生物治疗杂志,2023,30(4):296-301
and modeling[J]. Front Oncol,2022,12:790976 [21]刘 枫. DMTN调控EGFR通路促进胶质母细胞瘤恶性
[8] 刘若愚,薛 哲,赵 悦,等. 室管膜下区胶质母细胞瘤 生物学行为[D]. 沈阳:中国医科大学,2023
的临床特征及诊断治疗研究进展[J]. 现代肿瘤医学, [22]崔晓萍,陈建梅,叶建新,等. Nac⁃1在神经干/祖细胞自
2023,31(5):950-954 我更新维持中的作用[J]. 西安交通大学学报(医学
[9] PRATUMKAEW P,ISSARAGRISIL S,LUANPITPONG 版),2019,40(5):711-715
S. Induced pluripotent stem cells as a tool for modeling [23] GOFFART N,LOMBARD A,LALLEMAND F,et al.
hematologic disorders and as a potential source for cell⁃ CXCL12 mediates glioblastoma resistance to radiothera⁃
based therapies[J]. Cells,2021,10(11):3250 py in the subventricular zone[J]. Neuro Oncol,2017,19
[10]JONES C L,INGUVA A,JORDAN C T. Targeting energy (1):66-77
metabolism in cancer stem cells:progress and challenges [24] IRANMANESH Y ,JIANG B,FAVOUR O C,et al. Mi⁃
in leukemia and solid tumors[J]. Stem Cell,2021,28(3): tochondria’s role in the maintenance of cancer stem